“An Open-Label, Pilot Study to Evaluate the Benefits of Using Lyophilized Human Milk-Derived Nutritional Product (NeoLact 70 – 1.55 G) As an Immune-Nutritional Supplement in Premature Infants Discharged from NICU”. Indian Journal of Child Health, vol. 8, no. 12, Dec. 2021, pp. 404-7, https://doi.org/10.32677/ijch.v8i12.3213.